DIABETES CONTROL AND COMPLICATIONS TRIAL
(DCCT)
BIBLIOGRAPHY
With links to journal article abstracts where available
57. The Diabetes Control and Complications Trial Research Group. The effect
of intensive diabetes therapy on measures of autonomic nervous system function
in the Diabetes Control and Complications Trial (DCCT). Diabetologia,
41:416-423, 1998. Abstract
56. The Diabetes Control and Complications Trial Research Group. Effect of
intensive therapy on residual Beta-cell function in patients with type 1
diabetes in the Diabetes Control and Complications Trial: A randomized,
controlled trial. Annals of Internal Medicine, 128:517-523, 1998.
Journal Article
55. The Diabetes Control and Complications Trial Research Group. Early
worsening of diabetic retinopathy in the Diabetes Control and Complications
Trial. Archives of Ophthalmology, 116:874-886, 1998. Abstract
54. Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA and
Brunzell JD. Effect of excessive weight gain with intensive therapy of type 1
diabetes on lipid levels and blood pressure: Results from the DCCT. Journal
of the American Medical Association, 280:140-146, 1998. Abstract
53. The Diabetes Control and Complications Trial Research Group. Clustering
of long-term complications in families with diabetes in the Diabetes Control and
Complications Trial. Diabetes, 46:1829-1839, 1997. Abstract
52. The Diabetes Control and Complications Trial Research Group.
Hypoglycemia in the Diabetes Control and Complications Trail. Diabetes,
46:271-286, 1997. Abstract
51. The Diabetes Control and Complications Trial Research Group. The absence
of a glycemic threshold for the development of long-term complications: The
perspective of the Diabetes Control and Complications Trial. Diabetes,
45:1289-1298, 1996. Abstract
50. The Diabetes Control and Complications Trial Research Group. Lifetime
benefits and costs of intensive therapy as practiced in the Diabetes Control and
Complications Trial. Journal of the American Medical Association,
276:1409-1415, 1996. Abstract
49. The Diabetes Control and Complications Trial Research Group. Pregnancy
outcomes in the Diabetes Control and Complications Trial. American Journal
of Obstetrics and Gynecology,, 174:1343-1353, 1996.
Abstract
48. The Diabetes Control and Complications Trial Research Group. Influence
of intensive diabetes treatment on quality-of-life outcomes in the Diabetes
Control and Complications Trial. Diabetes Care, 19:195-203, 1996. Abstract
47. The Diabetes Control and Complications Trial Research Group. Effects of
intensive diabetes therapy on neuropsychological function in adults in the
Diabetes Control and Complications Trial. Annals of Internal Medicine,
124:379-388, 1996.Journal
Article
46. Leiter L, and the Diabetes Control and Complications Trial Research
Group. Use of bioelectrical impedance analysis measurements in patients with
diabetes. American Journal of Clinical Nutrition, 64 (suppl.):
515S-518S, 1996. Abstract
45. The Diabetes Control and Complications Trial Research Group. Effect of
intensive diabetes treatment on nerve conduction in the Diabetes Control and
Complications Trial. Annals of Neurology, 38:869-880, 1995. Abstract
44. The Diabetes Control and Complications Trial Research Group. Adverse
events and their association with treatment regimens in the Diabetes Control and
Complications Trial. Diabetes Care, 18:1415-1427, 1995. Abstract
43. The Diabetes Control and Complications Trial Research Group. Resource
utilization and costs of care in the Diabetes Control and Complications Trial.
Diabetes Care, 18:1468-1478, 1995. Abstract
42. Purnell JQ, Marcovina SM, Hokanson JE, Kennedy H, Cleary PA, Steffes MW,
and Brunzell JD. Levels of lipoprotein (a), apolipoprotein B, and lipoprotein
cholesterol distribution in IDDM. Results from follow-up in the Diabetes
Control and Complications Trial. Diabetes, 44:1218-1226, 1995. Abstract
41. The Diabetes Control and Complications Trial Research Group. The
relationship of glycemic exposure (HbA1c) to the risk of development
and progression of retinopathy in the Diabetes Control and Complications Trial.
Diabetes, 44:968-983, 1995. Abstract
40. The Diabetes Control and Complications Trial Research Group. Effect of
intensive diabetes management on macrovascular events and risk factors in the
Diabetes Control and Complications Trial. The American Journal of
Cardiology, 75:894-903, 1995. Abstract
39. The Diabetes Control and Complications (DCCT) Research Group. Effect of
intensive therapy on the development and progression of diabetic nephropathy in
the Diabetes Control and Complications Trial. Kidney International,
47:1703-1720, 1995. Abstract
38. The Diabetes Control and Complications Trial Research Group. The effect
of intensive diabetes therapy on the development and progression of neuropathy.
Annals of Internal Medicine, 122:561-568, 1995.
Journal Article
37. The Diabetes Control and Complications Trial Research Group; and Klein
R, Moss S. A comparison of the study populations in the Diabetes Control and
Complications Trial and the Wisconsin Epidemiologic Study of Diabetic
Retinopathy. Archives of Internal Medicine, 155:745-754, 1995. Abstract
36. The Diabetes Control and Complications Trial Research Group.
Progression of retinopathy with intensive versus conventional treatment in the
Diabetes Control and Complications Trial. Ophthalmology, 102:647-661,
1995.
Abstract
35. The Diabetes Control and Complications Trial Research Group. The effect
of intensive diabetes treatment on the progression of diabetic retinopathy in
insulin-dependent diabetes mellitus: The Diabetes Control and Complications
Trial. Archives of Ophthalmology, 113:36-51, 1995. Abstract
34. Diabetes Control and Complications Trial Research Group. Implementation
of treatment protocols in the Diabetes Control and Complications Trial. Diabetes
Care, 18:361-376, 1995.
Abstract
33. The Diabetes Control and Complications Trial Research Group.
Psychological aspects of the DCCT. In The Technology of Diabetes Care:
Converging Medical and Psychosocial Perspectives, 122-139, 1994.
32. Leiter LA, Lukaski HC, Kenny DJ, Barnie A, Camelon K, Ferguson RS,
MacLean S, Simkins S, Zinman B and Cleary PA for the DCCT Research Group. The
use of Bioelectrical Impedance Analysis (BIA) to estimate body composition in
the Diabetes Control and Complications Trial (DCCT). International Journal
of Obesity, 18:829-835, 1994. Abstract
31. Schmidt LE, Cox MS, Buzzard IM, and Cleary PA, for the DCCT Research
Group. Reproducibility of a comprehensive diet history in the Diabetes Control
and Complications Trial. Journal of the American Dietetic Association,
94:1392-1397, 1994. Abstract
30. Diabetes Control and Complications Trial Research Group. Effect of
intensive diabetes treatment on the development and progression of long-term
complications in adolescents with insulin-dependent diabetes mellitus: Diabetes
Control and Complications Trial. The Journal of Pediatrics,
125:177-188, 1994.
Abstract
29. The DCCT Research Group. A screening algorithm to identify clinically
significant changes in neuropsychological functions in the Diabetes Control and
Complications Trial. Journal of Clinical and Experimental Neuropsychology,
16:303-316, 1994. Abstract
28. Siebert C and Clark CM. Operational and policy considerations of data
monitoring in clinical trials: the Diabetes Control and Complications Trial
experience. Controlled Clinical Trials , 14(1): 30-44, 1993.
Abstract
27. The DCCT Research Group. The impact of the trial coordinator in the
Diabetes Control and Complications Trial. Diabetes Educator,
19:509-512, 1993. Abstract
26. Levey AS, Greene T, Schluchter MD, Cleary PA, Teschan PE, Lorenz RA,
Molitch ME, Mitch WE, Siebert C, Hall PM, and Steffes MW, for the Modification
of Diet in Renal Disease Study Group and the Diabetes Control and Complications
Trial Research Group. Glomerular filtration rate measurements in clinical
trials. Journal of the American Society of Nephrology, 4:1159-1171,
1993. Abstract
25. The Diabetes Control and Complications Trial Research Group. Nutrition
interventions for intensive therapy in the Diabetes Control and Complications
Trial. The Journal of the American Dietetic Association,
93:768-772, 1993.
Abstract
24. The DCCT Research Group. Expanded role of the dietitian in the Diabetes
Control and Complications Trial: Implications for clinical practice. The
Journal of the American Dietetic Association, 93:758-767, 1993. Abstract
23. The Diabetes Control and Complications Trial Research Group. The effect
of intensive treatment of diabetes on the development and progression of
long-term complications in insulin-dependent diabetes mellitus. The New
England Journal of Medicine, 329:977-986, 1993. Abstract
22. The Diabetes Control and Complications Trial Research Group. Baseline
analysis of renal function in the Diabetes Control and Complications Trial.
Kidney International, 43:668-674, 1993. Abstract
21. The DCCT Research Group. Lipid and lipoprotein levels in patients with
IDDM: Diabetes Control and Complications Trial Experience. Diabetes Care,
15:886-894, 1992. Abstract
20. Ryan CM, Adams KA, Heaton RK, Grant I, Jacobson AM and the DCCT Research
Group. Neurobehavioral assessment of medical patients in clinical trials: The
DCCT Experience. In Handbook of Clinical Trials; The Neurobehavioral
Approach. Erich Mohr and Pim Brouwers, Eds. Amsterdam/Lisse: Swets and
Zeitlinger, 215-241, 1991.
19. The DCCT Research Group. Epidemiology of severe hypoglycemia in the
Diabetes Control and Complications Trial. The American Journal of Medicine,
90:450-59, 1991. Abstract
18. The DCCT Research Group. The Diabetes Control and Complications Trial
(DCCT): Update. Diabetes Care, 13:427-433, 1990. Abstract
17. The DCCT Research Group. The Diabetes Control and Complications Trial
(DCCT): The trial coordinator perspective. Diabetes Educator,
15:236-241, 1989. Abstract
16. The DCCT Research Group. The DCCT: Will it answer the questions? Diabetes
1988, R. Larkins, P. Zimmet, D. Chisolm, editors, Elsevier Science
Publishers B.V. (Biomedical Division), 847-855, 1989.
15. The DCCT Research Group. The Diabetes Control and Complications Trial
(DCCT): Results of the feasibility study and design of the full-scale clinical
trial. Pediatric and Adolescent Endocrinology, Laron Z, Karp M (eds)
Basel, Karger, 18:15-21, 1989.
14. The DCCT Research Group. Implementation of a multicomponent process to
obtain informed consent in the Diabetes Control and Complications Trial. Controlled
Clinical Trials, 10:83-96, 1989. Abstract
13. The DCCT Research Group. Update. Diabetes Spectrum, 1:187-190,
1988.
12. The DCCT Research Group. Reliability and validity of diabetes
quality-of-life measure for the Diabetes Control and Complications Trial (DCCT).
Diabetes Care, 11:725-732, 1988. Abstract
11. The DCCT Research Group. Weight gain associated with intensive therapy
in the Diabetes Control and Complications Trial. Diabetes Care,
11:567-573, 1988. Abstract
10. Schumer M, Burton G, Burton C, Crum D, Pfeifer MA, the DCCT Study Group.
Diabetic autonomic neuropathy-Part I: Autonomic nervous system data analysis
by a computerized central unit in a multicenter trial. The American Journal
of Medicine, 85 (suppl. 5A):137-143, 1988.
9. Hanssen KF, The DCCT Research Group, and Brunetti P. Is there a need for
a continuation of the DCCT in 1988? Diabetes Nutrition and Metabolism,
1:151-159, 1988.
8. The DCCT Research Group. Factors in development of diabetic neuropathy:
Baseline analysis of neuropathy in feasibility phase of the Diabetes Control and
Complications Trial (DCCT). Diabetes, 37:476-481, 1988. Abstract
7. The DCCT Research Group. Are continuing studies of metabolic control and
microvascular complications in insulin-dependent diabetes mellitus justified?
The Diabetes Control and Complications Trial. The New England Journal of
Medicine, 318:246-250, 1988.
6. The Diabetes Control and Complications Trial Research Group. Color
photography vs. fluorescein angiography in the detection of diabetic retinopathy
in the Diabetes Control and Complications Trial. Archives of Ophthalmology,
105:1344-1351, 1987. Abstract
5. The DCCT Research Group. Diabetes Control and Complications Trial
(DCCT): results of feasibility study. Diabetes Care, 10:1-19, 1987. Abstract
4. The DCCT Research Group. Feasibility of centralized measurements of
glycated hemoglobin in the Diabetes Control and Complications Trial: A
multicenter study. Clinical Chemistry, 33:2267-2271, 1987. Abstract
3. The DCCT Research Group. Effects of age, duration and treatment of
insulin-dependent diabetes mellitus on residual Beta-cell function: Observations
during eligibility testing for the Diabetes Control and Complications Trial
(DCCT). Journal of Clinical Endocrinology and Metabolism, 65:30-36,
1987. Abstract
2. The DCCT Research Group. Treatment regimen design in the Diabetes
Control and Complications Trial (DCCT). Transplantation Proceedings,
XVIII(6):1678-1680, 1986.
1. The DCCT Research Group. The Diabetes Control and Complications Trial
(DCCT): Design and methodologic considerations for the feasibility phase. Diabetes,
35:530-545, 1986. Abstract
| 